Global Blood Therapeutics, Inc.
GBT · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$303 | -$248 | -$267 | -$174 |
| Dep. & Amort. | $9 | $11 | $10 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $79 | $71 | $46 | $30 |
| Change in WC | -$42 | -$47 | $27 | $5 |
| Other Non-Cash | $1 | $1 | -$10 | -$1 |
| Operating Cash Flow | -$257 | -$212 | -$194 | -$135 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$9 | -$3 | -$5 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$50 | -$58 | -$435 | -$361 |
| Inv. Sales/Matur. | $66 | $384 | $361 | $182 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $12 | $317 | -$77 | -$184 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $46 | $0 | $219 | $397 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $434 | $87 | $298 | $398 |
| Financing Cash Flow | $434 | $87 | $298 | $398 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $190 | $193 | $27 | $78 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $497 | $305 | $278 | $199 |
| End Cash | $687 | $497 | $305 | $278 |
| Free Cash Flow | -$260 | -$221 | -$198 | -$140 |